The effects of cinacalcet in older and younger patients on hemodialysis: The evaluation of cinacalcet HCL therapy to lower cardiovascular events (EVOLVE) trial
(583)
Parfrey, Patrick S
a
Drüeke, Tilman B
b
Block, Geoffrey A
c
Correa Rotter, Ricardo
d
Floege, Jürgen
e
Herzog, Charles A
f
London, Gerard M
g
Mahaffey, Kenneth W
h
Moe, Sharon M
i
Wheeler, D
l
Kubo, Yumi
k
Dehmel, Bastian
k
Goodman, William G
k
Chertow, Glenn M
h
Santos, J
l
Najun Zarazaga, C
l
Marin, I
l
Garrote, N
l
Cusumano, A
l
Penalba N
l
Del Valle, E
l
Juncos, L
l
Martinez Saye, J
l
Lef, L
l
Altobelli, V
l
Petraglia, G
l
Rosa Diez, G
l
Douthat, W
l
Lobo, J
l
Gallart, C
l
Lafalla, A
l
Diez, G
l
Linares, B
l
Lopez, N
l
Ramirez, N
l
Gonzalez, R
l
Valtuille, R
l
Beresan, H
l
Hermida, O
l
Rudolf, G
l
Marchetta, N
l
Rano, M
l
Ramirez, M
l
Garcia N
l
Gillies, A
l
Jones, B
l
Pedagogos, E
l
Walker, R
l
Talaulikar, G
l
Bannister, K
l
Suranyi, M
l
Kark, A
l
Roger, S
l
Kerr, P
l
Disney, A
l
Mount, P
l
Fraenkel, M
l
Mathew, M
l
Fassett, R
l
Jose, M
l
Hawley, C
l
Lonergan, M
l
Mackie, J
l
Ferrari, P
l
Menahem, S
l
Sabto, J
l
Hutchison, B
l
Langham, R
l
Pollock, C
l
Holzer, H
l
Oberbauer, R
l
Arias, I
l
Graf, H
l
Mayer, G
l
Lhotta, K
l
Neyer, U
l
Klauser, R
l
Hoerl, W
l
Horn, S
l
Kovarik, J
l
Kramar, R
l
Eigner, M
l
Dhaene, M
l
Billiouw, J
l
De Meester, J
l
Warling, X
l
Cambier Dwelschauwers, P
l
Evenepoel, P
l
Daelemans, R
l
Dratwa, M
l
Maes, B
l
Stolear, J
l
Dejagere, T
l
Vanwalleghem, J
l
Bouman, K
l
Jadoul, M
l
Peeters, J
l
Vanholder, R
l
Tielemans, C
l
Donck, J
l
Almeida, F
l
Picollo de Oliveira, J
l
Burdmann, E
l
Garcia, V
l
Saldanha Thome, F
l
Deboni, L
l
Bregman, R
l
Lugon, J
l
Araujo S
l
Ferreira Filho, S
l
de Francesco Daher, E
l
Sperto Baptista, M
l
Carvalho, A
l
d'Avila D
l
Moyses Neto, M
l
Yu, L
l
Bastos, M
l
Sampaio Lacativa, P
l
Jorgetti, V
l
de Almeida Romao E
l
Cardeal da Costa, J
l
Pecoits Filho, R
l
Gordan, P
l
Salgado, N
l
Teixeira Araujo M
l
Neiva Coelho, S
l
Oliveira, I
l
Moyses R
l
Vasconcellos, L
l
Batista, P
l
Luiz Gross, J
l
Pedrosa, A
l
Cournoyer, S
l
LeBlanc, M
l
Chow, S
l
Karunakaran, S
l
Wong, G
l
Tobe, S
l
Desmeules, S
l
Zimmerman, D
l
Murphy, S
l
Montambault, P
l
Donnelly, S
l
MacRae, J
l
Culleton, B
l
Soroka, S
l
Rabbat, C
l
Jindal, K
l
Vasilevsky, M
l
Michaud, M
l
Wijeyesinghe, E
l
Zacharias, J
l
Lok, C
l
Muirhead, N
l
Verrelli, M
l
Da Roza, G
l
Sapir, D
l
Olgaard, K
l
Daugaard, H
l
Brandi, L
l
Jensen, P
l
Boulechfar, H
l
Ang, K
l
Simon, P
l
Rieu, P
l
Brunet, P
l
Touchard, G
l
London, G
l
Urena Torres, P
l
Combe, C
l
Durrbach, A
l
Ortiz, J
l
Hannedouche, T
l
Vela, C
l
Lionet, A
l
Ryckelynck, P
l
Zaoui, P
l
Choukroun, G
l
Fessi, H
l
Lang, P
l
Stroumza, P
l
Joly, D
l
Mousson, C
l
Laville, M
l
Dellanna, F
l
Erley, C
l
Braun, J
l
Rambausek, M
l
Riegel, W
l
Klingberg, M
l
Schwertfeger, E
l
Wizemann, V
l
Eckardt, K
l
Reichel, H
l
Passauer, J
l
Hubel E
l
Frischmuth, N
l
Liebl, R
l
Fiedler, R
l
Schwenger, V
l
Vosskuhler A
l
Kunzendorf, U
l
Renders, L
l
Rattensberger, D
l
Rump, L
l
Ketteler, M
l
Neumayer, H
l
Zantvoort, F
l
Stahl, R
l
Ladanyi, E
l
Kulcsar, I
l
Mezei, I
l
Csiky, B
l
Rikker, C
l
Arkossy, O
l
Berta, K
l
Szegedi, J
l
Major, L
l
Ferenczi, S
l
Fekete, A
l
Szabo, T
l
Zakar, G
l
Wagner, G
l
Kazup Erdelyine, S
l
Borbas, B
l
Eustace, J
l
Reddan, D
l
Capasso, G
l
Locatelli, F
l
Villa, G
l
Cozzolino, M
l
Brancaccio, D
l
Messa, P
l
Bolasco, P
l
Ricciardi, B
l
Malberti, F
l
Moriero, E
l
Cannella, G
l
Ortalda, V
l
Stefoni, S
l
Frasca G
l
Cappelli, G
l
Albertazzi, A
l
Zoccali, C
l
Farina, M
l
Elli, A
l
Avella, F
l
Ondei, P
l
Mingardi, G
l
Errico, R
l
Losito, A
l
Di Giulio, S
l
Pertosa, G
l
Schena, F
l
Grandaliano, G
l
Gesualdo, L
l
Auricchio, M
l
Bochicchio Ricardelli, T
l
Aranda Verastegui F
l
Pena J
l
Chew Wong, A
l
Cruz Valdez, J
l
Torres Zamora, M
l
Solis, M
l
Sebastian Diaz, M
l
Vital Flores, M
l
Alvarez Sandoval, E
l
van den Dorpel, M
l
Brink, H
l
Van Kuijk, W
l
Vermeij, C
l
Smak Gregoor, P
l
Hagen, E
l
van der Sande, F
l
Klinger, M
l
Nowicki, M
l
Muszytowski, M
l
Bidas, K
l
Bentkowski, W
l
Wiecek, A
l
Ksiazek, A
l
Marczewski, K
l
Ostrowski, M
l
Switalski, M
l
Sulowicz, W
l
Matuszkiewicz Rowinska, J
l
Mysliwiec, M
l
Durlik, M
l
Rutkowski, B
l
Macario, F
l
Carvalho, B
l
Frazao, J
l
Machado, D
l
Weigert, A
l
Andrusev, A
l
Khrustalev, O
l
Zemtchenkov, A
l
Gurevich, K
l
Staroselsky, K
l
Khadikova, N
l
Rozhinskaya, L
l
Timokhovskaya, G
l
Strokov, A
l
Balkarova, O
l
Ermolenko, V
l
Kolmakova, E
l
Komandenko, M
l
Timofeev, M
l
Shilo, V
l
Shostka, G
l
Smirnov, A
l
Anashkin, V
l
Volgina, G
l
Domashenko, O
l
Gurevich, A
l
Perlin, D
l
Martinez Garcia J
l
Andres Ribes E
l
Coll Piera, E
l
Fernandez Lucas, M
l
Galicia, M
l
Prados, M
l
Gonzalez M
l
Romero, R
l
Martin de Francisco A
l
Montenegro, J
l
Santiago, C
l
Garcia F
l
Alcazar de La Ossa J
l
Arrieta, J
l
Pons, J
l
Martin Malo A
l
Soler Amigo J
l
Cases, A
l
Sterner, G
l
Jensen, G
l
Wikstrom B
l
Jacobson, S
l
Lund, U
l
Weiss, L
l
Stahl A
l
von Albertini, B
l
Burnier, M
l
Meier, P
l
Martin, P
l
Uehlinger, D
l
Dickenmann, M
l
Yaqoob, M
l
Zehnder, D
l
Kalra, P
l
Padmanabhan, N
l
Roe, S
l
Eadington, D
l
Pritchard, N
l
Hutchison, A
l
Davies, S
l
Wilkie, M
l
Davies, M
l
Pai, P
l
Swift, P
l
Kwan, J
l
Goldsmith, D
l
Tomson, C
l
Stratton, J
l
Dasgupta, I
l
Sarkar, S
l
Moustafa, M
l
Gandhi, K
l
Jamal, A
l
Galindo Ramos, E
l
Tuazon, J
l
Batlle, D
l
Tucker, K
l
Schiller Moran, B
l
Assefi, A
l
Martinez, C
l
Samuels, L
l
Goldman, J
l
Cangiano Rivera, J
l
Darwish, R
l
Lee, M
l
Topf, J
l
Kapatkin, K
l
Baer, H
l
Kopelman, R
l
Acharya, M
l
Tharpe, D
l
Bernardo, M
l
Nader, P
l
Guzman Rivera, J
l
Pergola, P
l
Sekkarie, M
l
Alas, E
l
Zager, P
l
Liss, K
l
Navarro, J
l
Roppolo, M
l
Denu Ciocca, C
l
Kshirsagar, A
l
El Khatib, M
l
Kant, K
l
Scott, D
l
Murthyr, B
l
Finkelstein, F
l
Keightley, G
l
McCrary, R
l
Pitone, J
l
Cavalieri, T
l
Tsang, A
l
Pellegrino, B
l
Schmidt, R
l
Ahmad, S
l
Brown, C
l
Friedman, E
l
Mittman, N
l
Fadem, S
l
Shapiro, W
l
Reddy, M
l
Goldberger, S
l
Woredekal, Y
l
Agarwal, A
l
Anger, M
l
Haque, M
l
Chidester, P
l
Kohli, R
l
Rubinstein, S
l
Newman, G
l
Gladish, R
l
Ayodeji, O
l
Soman, S
l
Sprague, S
l
Hunt, N
l
Gehr, T
l
Rizk, D
l
Warnock, D
l
Polack, D
l
Pahl, M
l
Fischer, D
l
Dreyer, P
l
James, G
l
Husserl, F
l
Rogers, T
l
Raff, A
l
Sedor, J
l
Silver, M
l
Smith, M
l
Steinberg, S
l
DelGiorno, T
l
Jones, E
l
Cunha, P D
l
Cheng, J
l
Pogue, V
l
Blumenthal, S
l
Brown, E
l
Charytan, C
l
Buerkert, J
l
Cook, M
l
Felsenfeld, A
l
Tareen, N
l
Gupta, A
l,l
Herman, T
l
Diamond, S
l
Hura, C
l
Laski, M
l
MacLaurin, J
l
Plumb, T
l
Brosnahan, G
l
Kumar, J
l
Henriquez, M
l
Poole, C
l
Osanloo, E
l
Matalon, A
l
Sholer, C
l
Arfeen, S
l
Azer, M
l
Belledonne, M
l
Gross, M
l
Dunnigan, E
l
McConnell, K
l
Becker, B
l
Skinner, F
l
Rigolosi, R
l
Spiegel, D
l
Stegman, M
l
Patak, R
l
Streja, D
l
Ranjit, U
l
Youell, T
l
Wooldridge, T
l
Stafford, C
l
Cottiero, R
l
Weinberg, M
l
Schonefeld, M
l
Shahmir, E
l
Hazzan, A
l
Ashfaq, A
l
Bhandari, K
l
Cleveland, W
l
Culpepper, M
l
Golden, J
l
Lai, L
l
Lien, Y
l
Lorica, V
l
Robertson, J
l
Malireddi, K
l
Morse, S
l
Thakur, V
l
Israelit, A
l
Raguram, P
l
Alfred, H
l
Weise, W
l
Al Saghir, F
l
El Shahawy, M
l
Rastogi, A
l
Nissenson, A
l
Kopyt, N
l
Lynn, R
l
Lea, J
l
McClellan, W
l
Teredesai, P
l
Ong, S
l
Tolkan, S
l
Sugihara, J
l
Minga, T
l
Mehrotra, R
l
Minasian, R
l
Bhatia, D
l
Specter, R
l
Capelli, J
l
Sidhu, P
l
Dalal, S
l
Dykes, P
l
Khan, M
l
Rahim, F
l
Saklayen, M
l
Thomas, A
l
Michael, B
l
Torres, M
l
Al Bander, H
l
Murray, B
l
Abukurah, A
l
Gupta, B
l
Nosrati, S
l
Raja, R
l
Zeig, S
l
Braun, M
l
Amatya, A
l
Endsley, J
l
Sharon, Z
l
Dolson, G
l
Dumler, F
l
Ntoso, K
l
Rosansky, S
l
Kumar, N
l
Gura, V
l
Thompson, N
l
Goldfarb, D
l
Halligan, R
l
Middleton, J
l
Widerhorn, A
l
Arbeit, L
l
Arruda, J
l
Crouch, T
l
Friedman, L
l
Khokhar, S
l
Mittleman, J
l
Light, P
l
Taparia, B
l
West, C
l
Cotton, J
l
Dhingra, R
l
Kleinman, L
l
Arif, F
l
Lew, S
l
Nammour, T
l
Sterrett, J
l
Williams, M
l
Ramirez, J
l
Rubin, J
l
McCarthy, J
l
Noble, S
l
Chaffin, M
l
Rekhi, A
l
more..
|
-
1
-
-
20544467918
-
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999
-
Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16: 489–495, 2005
-
(2005)
J am Soc Nephrol
, vol.16
, pp. 489-495
-
-
Foley, R.N.1
Murray, A.M.2
Li, S.3
Herzog, C.A.4
McBean, A.M.5
Eggers, P.W.6
Collins, A.J.7
-
2
-
-
0031733696
-
Clinical epidemiology of cardiovascular disease in chronic renal disease
-
Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 [Suppl 3]: S112–S119, 1998
-
(1998)
Am J Kidney Dis
, vol.32
, pp. S112-S119
-
-
Foley, R.N.1
Parfrey, P.S.2
Sarnak, M.J.3
-
3
-
-
68949114585
-
Improving Global Outcomes (KDIGO) CKDMBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic KidneyDisease-Mineral and BoneDisorder (CKD-MBD)
-
Kidney Disease
-
Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic KidneyDisease-Mineral and BoneDisorder (CKD-MBD). Kidney Int Suppl 76: S1–S130, 2009
-
(2009)
Kidney Int Suppl
, vol.76
, pp. SS1-S130
-
-
-
4
-
-
0042885985
-
Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality
-
London GM, Guérin AP, Marchais SJ, Meétivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731–1740, 2003
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 1731-1740
-
-
London, G.M.1
Guérin, A.P.2
Marchais, S.J.3
Meétivier, F.4
Pannier, B.5
Adda, H.6
-
5
-
-
84896698667
-
Mechanisms of arterial calcifications and consequences for cardiovascular function
-
2013
-
London GM: Mechanisms of arterial calcifications and consequences for cardiovascular function. Kidney Int Suppl (2011) 3: 442–445, 2013
-
(2011)
Kidney Int Suppl
, vol.3
, pp. 442-445
-
-
London, G.M.1
-
6
-
-
84862498822
-
Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease
-
Torres PA, De Broe M: Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease. Kidney Int 82: 19–25, 2012
-
(2012)
Kidney Int
, vol.82
, pp. 19-25
-
-
Torres, P.A.1
De Broe, M.2
-
7
-
-
11144353767
-
Cinacalcet for secondary hyperparathyroidismin patients receiving hemodialysis
-
Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drüeke TB, Goodman WG: Cinacalcet for secondary hyperparathyroidismin patients receiving hemodialysis. N Engl J Med 350: 1516–1525, 2004
-
(2004)
N Engl J Med
, vol.350
, pp. 1516-1525
-
-
Block, G.A.1
Martin, K.J.2
De Francisco, A.L.3
Turner, S.A.4
Avram, M.M.5
Suranyi, M.G.6
Hercz, G.7
Cunningham, J.8
Abu-Alfa, A.K.9
Messa, P.10
Coyne, D.W.11
Locatelli, F.12
Cohen, R.M.13
Evenepoel, P.14
Moe, S.M.15
Fournier, A.16
Braun, J.17
McCary, L.C.18
Zani, V.J.19
Olson, K.A.20
Drüeke, T.B.21
Goodman, W.G.22
more..
-
8
-
-
67349157697
-
The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (ApoE-/-) mice
-
Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri R, Maizel J, Hamada Y, Nguyen-Khoa T, Fukagawa M, Kamel S, Lacour B, Drüeke TB, Massy ZA: The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis 205: 55–62, 2009
-
(2009)
Atherosclerosis
, vol.205
, pp. 55-62
-
-
Ivanovski, O.1
Nikolov, I.G.2
Joki, N.3
Caudrillier, A.4
Phan, O.5
Mentaverri, R.6
Maizel, J.7
Hamada, Y.8
Nguyen-Khoa, T.9
Fukagawa, M.10
Kamel, S.11
Lacour, B.12
Drüeke, T.B.13
Massy, Z.A.14
-
9
-
-
58049199370
-
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
-
Koleganova N, Piecha G, Ritz E, Schmitt CP, Gross ML: A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int 75: 60–71, 2009
-
(2009)
Kidney Int
, vol.75
, pp. 60-71
-
-
Koleganova, N.1
Piecha, G.2
Ritz, E.3
Schmitt, C.P.4
Gross, M.L.5
-
10
-
-
84893032723
-
Calcimimetics increase CaSR expression and reducemineralization in vascular smoothmuscle cells:Mechanisms of action
-
Hénaut L, Boudot C, Massy ZA, Lopez-Fernandez I, Dupont S, Mary A, Drüeke TB, Kamel S, Brazier M, Mentaverri R: Calcimimetics increase CaSR expression and reducemineralization in vascular smoothmuscle cells:Mechanisms of action. Cardiovasc Res 101: 256–265, 2014
-
(2014)
Cardiovasc Res
, vol.101
, pp. 256-265
-
-
Hénaut, L.1
Boudot, C.2
Massy, Z.A.3
Lopez-Fernandez, I.4
Dupont, S.5
Mary, A.6
Drüeke, T.B.7
Kamel, S.8
Brazier, M.9
Mentaverri, R.10
-
11
-
-
79953903052
-
A randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis
-
ADVANCE Study Group: The ADVANCE study
-
Raggi P, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K, Moustafa M, Goodman WG, Lopez N, Downey G, Dehmel B, Floege J; ADVANCE Study Group: The ADVANCE study: A randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 26: 1327–1339, 2011
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 1327-1339
-
-
Raggi, P.1
Chertow, G.M.2
Torres, P.U.3
Csiky, B.4
Naso, A.5
Nossuli, K.6
Moustafa, M.7
Goodman, W.G.8
Lopez, N.9
Downey, G.10
Dehmel, B.11
Floege, J.12
-
12
-
-
84871675923
-
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis
-
EVOLVE Trial Investigators
-
Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS; EVOLVE Trial Investigators: Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367: 2482–2494, 2012
-
(2012)
N Engl J Med
, vol.367
, pp. 2482-2494
-
-
Chertow, G.M.1
Block, G.A.2
Correa-Rotter, R.3
Drüeke, T.B.4
Floege, J.5
Goodman, W.G.6
Herzog, C.A.7
Kubo, Y.8
London, G.M.9
Mahaffey, K.W.10
Mix, T.C.11
Moe, S.M.12
Trotman, M.L.13
Wheeler, D.C.14
Parfrey, P.S.15
-
13
-
-
84889858477
-
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: The EVOLVE trial
-
Parfrey PS, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Dehmel B, Trotman ML, Modafferi DM, Goodman WG: The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: The EVOLVE trial. J Clin Endocrinol Metab 98: 4834–4844, 2013
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. 4834-4844
-
-
Parfrey, P.S.1
Chertow, G.M.2
Block, G.A.3
Correa-Rotter, R.4
Drüeke, T.B.5
Floege, J.6
Herzog, C.A.7
London, G.M.8
Mahaffey, K.W.9
Moe, S.M.10
Wheeler, D.C.11
Dehmel, B.12
Trotman, M.L.13
Modafferi, D.M.14
Goodman, W.G.15
-
14
-
-
34548821615
-
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and design overview
-
Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P: Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J AmSoc Nephrol 2: 898–905, 2007
-
(2007)
Clin J Amsoc Nephrol
, vol.2
, pp. 898-905
-
-
Chertow, G.M.1
Pupim, L.B.2
Block, G.A.3
Correa-Rotter, R.4
Drueke, T.B.5
Floege, J.6
Goodman, W.G.7
London, G.M.8
Mahaffey, K.W.9
Moe, S.M.10
Wheeler, D.C.11
Albizem, M.12
Olson, K.13
Klassen, P.14
Parfrey, P.15
-
15
-
-
84864398955
-
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial
-
Chertow GM, Correa-Rotter R, Block GA, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Wheeler DC, Parfrey PS: Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant 27: 2872–2879, 2012
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 2872-2879
-
-
Chertow, G.M.1
Correa-Rotter, R.2
Block, G.A.3
Drueke, T.B.4
Floege, J.5
Goodman, W.G.6
Herzog, C.A.7
Kubo, Y.8
London, G.M.9
Mahaffey, K.W.10
Mix, T.C.11
Moe, S.M.12
Wheeler, D.C.13
Parfrey, P.S.14
-
16
-
-
84865688452
-
Vascular calcification: Pathophysiology and risk factors
-
Chen NX, Moe SM: Vascular calcification: Pathophysiology and risk factors. Curr Hypertens Rep 14: 228–237, 2012
-
(2012)
Curr Hypertens Rep
, vol.14
, pp. 228-237
-
-
Chen, N.X.1
Moe, S.M.2
-
17
-
-
0033967686
-
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
-
Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K: Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 15: 218–223, 2000
-
(2000)
Nephrol Dial Transplant
, vol.15
, pp. 218-223
-
-
Schwarz, U.1
Buzello, M.2
Ritz, E.3
Stein, G.4
Raabe, G.5
Wiest, G.6
Mall, G.7
Amann, K.8
-
18
-
-
34548529829
-
Calcification of coronary intima and media: Immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients
-
Gross ML, Meyer HP, Ziebart H, Rieger P, Wenzel U, Amann K, Berger I, Adamczak M, Schirmacher P, Ritz E: Calcification of coronary intima and media: Immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2: 121–134, 2007
-
(2007)
Clin J am Soc Nephrol
, vol.2
, pp. 121-134
-
-
Gross, M.L.1
Meyer, H.P.2
Ziebart, H.3
Rieger, P.4
Wenzel, U.5
Amann, K.6
Berger, I.7
Adamczak, M.8
Schirmacher, P.9
Ritz, E.10
-
19
-
-
84857176404
-
The risk for medial arterial calcification in CK
-
Hassan NA, D’Orsi ET, D’Orsi CJ, O’Neill WC: The risk for medial arterial calcification in CKD. Clin J Am Soc Nephrol 7: 275–279, 2012
-
(2012)
Clin J am Soc Nephrol
, vol.7
, pp. 275-279
-
-
Hassan, N.A.1
D’Orsi, E.T.2
D’Orsi, C.J.3
O’Neill, W.C.D.4
-
20
-
-
60749133542
-
Peripheral vascular calcification in long-haemodialysis patients: Associated factors and survival consequences
-
Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C: Peripheral vascular calcification in long-haemodialysis patients: Associated factors and survival consequences. Nephrol Dial Transplant 24: 948–955, 2009
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 948-955
-
-
Jean, G.1
Bresson, E.2
Terrat, J.C.3
Vanel, T.4
Hurot, J.M.5
Lorriaux, C.6
Mayor, B.7
Chazot, C.8
-
21
-
-
54749090958
-
Association of bone activity, calciumload, aortic stiffness, and calcifications in ESR
-
London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul M-C: Association of bone activity, calciumload, aortic stiffness, and calcifications in ESRD. J AmSoc Nephrol 19: 1827–1835, 2008
-
(2008)
J Amsoc Nephrol
, vol.19
, pp. 1827-1835
-
-
London, G.M.1
Marchais, S.J.2
Guérin, A.P.3
Boutouyrie, P.4
Métivier, F.5
De Vernejoul, M.-C.D.6
-
22
-
-
84859726995
-
Credibility of claims of subgroup effects in randomised controlled trials: Systematic review
-
Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, Bala MM, Bassler D, Mertz D, Diaz-Granados N, Vandvik PO, Malaga G, Srinathan SK, Dahm P, Johnston BC, Alonso-Coello P, Hassouneh B, Walter SD, Heels-Ansdell D, Bhatnagar N, Altman DG, Guyatt GH: Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ 344: e1553, 2012
-
(2012)
BMJ
, vol.344
-
-
Sun, X.1
Briel, M.2
Busse, J.W.3
You, J.J.4
Akl, E.A.5
Mejza, F.6
Bala, M.M.7
Bassler, D.8
Mertz, D.9
Diaz-Granados, N.10
Vandvik, P.O.11
Malaga, G.12
Srinathan, S.K.13
Dahm, P.14
Johnston, B.C.15
Alonso-Coello, P.16
Hassouneh, B.17
Walter, S.D.18
Heels-Ansdell, D.19
Bhatnagar, N.20
Altman, D.G.21
Guyatt, G.H.22
more..
-
23
-
-
35349004713
-
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
-
Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK: Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 72: 1130–1137, 2007
-
(2007)
Kidney Int
, vol.72
, pp. 1130-1137
-
-
Suki, W.N.1
Zabaneh, R.2
Cangiano, J.L.3
Reed, J.4
Fischer, D.5
Garrett, L.6
Ling, B.N.7
Chasan-Taber, S.8
Dillon, M.A.9
Blair, A.T.10
Burke, S.K.11
|